ulrich medical USA® Announces Product Line Extension Releases uCerv® Titanium Cervical Interbody System

/in /by

Continues with Spine Implant Portfolio Expansion for ACDF Spine Surgery

ST. LOUIS, MO (September 26, 2016) – ulrich medical USA, Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, today announced the U.S. market release of uCerv titanium spinal implants as an adjunct to its current uCerv PEEK OPTIMA® Interbody System which is an existing product used for anterior cervical discectomy and fusion (ACDF) surgical procedures.

Read more

ulrich medical USA® Announces Market Release of neon3 Posterior Cervical System

/in /by

Introduces New Flagship Product to Anchor U.S. Cervical Spine Implant Portfolio

ST. LOUIS, MO (July 13, 2016) – ulrich medical USA, Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, announced today the market release of the neon3™ Posterior Cervical System, which is intended to provide immobilization and stabilization of spinal segments as an adjunct to fusion or for a number of acute and chronic instabilities of the cervical and thoracic spine.

Read more

ulrich medical USA® Announces Market Release of uNion® Cervical Plate System

/in /by

Continues Expansion of U.S. Spinal Implant Product Portfolio

ST. LOUIS, MO (March 3, 2016) – ulrich medical USA Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, announced today the market release of the uNion Cervical Plate System – a titanium alloy spinal implant device used to provide mechanical stabilization and anterior fixation of the cervical spine as an adjunct to fusion for the treatment of degenerative disc disease.

Read more

ulrich medical USA® Announces Strong Financial Performance of U.S. Spine Business

/in /by

Delivers Record-Breaking 5-Year Results ~ 18% Revenue CAGR and 27% EBITDA CAGR

ST. LOUIS, MO (February 17, 2016) – ulrich medical USA Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, today reported a fifth consecutive year of profitable, double-digit growth for the U.S. spine business and a 20% top line growth for the year ending December 31, 2015. Equally as strong, the company announced a 5-year revenue compound annual growth rate (CAGR) of 18% and a 27% EBITDA CAGR over the same period.

Read more